Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
225,970,109
-
Total 13F shares
-
226,170,388
-
Share change
-
+695,423
-
Total reported value
-
$49,620,249,094
-
Put/Call ratio
-
70%
-
Price per share
-
$219.70
-
Number of holders
-
914
-
Value change
-
+$136,418,805
-
Number of buys
-
362
-
Number of sells
-
463
Institutional Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q1 2018
As of 31 Mar 2018,
Elevance Health, Inc. - Common Stock (ELV) was held by
914 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
226,170,388 shares.
The largest 10 holders included
BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, STATE STREET CORP, FMR LLC, BAILLIE GIFFORD & CO, Viking Global Investors LP, Invesco Ltd., WELLINGTON MANAGEMENT GROUP LLP, and NORTHERN TRUST CORP.
This page lists
915
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.